AxiomOne,
I had the same impression about the CC.
It is getting obvious now with the order from Middle East that commercially they get the business going finally. The test is demanded by the market and people will pay for it. Also the prospects in China, Russia and India are clearly bright.
However the financial situation remains a problem.
One final remark.
The price of 2,5$ should not be understood as THE one and only price. This is about the price for OTC in Middle East at the moment depending on a specific pricing strategy used now for market penetration in the region.
It can be quite different in China, it can be different for OTC elsewhere and it can be even different in a few months in the Middle East.
In any case, the test is competitive obviously and demand is developing. So this is one important aspect of this investment which I don't worry anymore.
Good luck
Cal
